Dana E. Moseson
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
Publications
31
Citations
1,113
Est. group size
~2
Recurring co-author estimate
Active years
14
Publishing since 2011
Dana E. Moseson works on improving how poorly water-soluble drugs are formulated and delivered in the body, with a particular focus on amorphous solid dispersions - a technique where a drug is mixed into a stabilizing polymer to make it dissolve more easily. This research covers manufacturing methods like hot-melt extrusion, how these formulations behave when dissolving in simulated or real intestinal fluids, and how factors like crystallinity, polymer choice, and processing conditions affect drug release and stability.
Publication output has grown from none in 2017 to a peak of 7 in 2021, with continued steady activity of 4-6 papers per year through 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Amorphous solubility advantage: Theoretical considerations, experimental methods, and contemporary relevance
Journal of Pharmaceutical Sciences · 2024
- Role of rheology in formulation and process design of hot melt extruded amorphous solid dispersions
International Journal of Pharmaceutics · 2024
- Dissolution of copovidone-based amorphous solid dispersions: Influence of atomic layer coating, hydration kinetics, and formulation
Journal of Pharmaceutical Sciences · 2024
- Dissolution, phase behavior and mass transport of amorphous solid dispersions in aspirated human intestinal fluids
Journal of Pharmaceutical Sciences · 2024
- Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions
Molecular Pharmaceutics · 2023
- Drug Dissolution in Oral Drug Absorption: Workshop Report
The AAPS Journal · 2023
- Control of drug release kinetics from hot-melt extruded drug-loaded polycaprolactone matrices
Journal of Controlled Release · 2023
- Voices in <i>Molecular Pharmaceutics</i>: Meet Dr. Dana Moseson, Tackling the Next Generation of Amorphous Solid Dispersion Formulation and Manufacturing Challenges
Molecular Pharmaceutics · 2023
- Erratum to: Amorphous solid dispersions containing residual crystallinity: Influence of seed properties and polymer adsorption on dissolution performance
European Journal of Pharmaceutical Sciences · 2022
- Exploring the Role of Surfactants in Enhancing Drug Release from Amorphous Solid Dispersions at Higher Drug Loadings
Pharmaceutics · 2021
- Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy
Molecular Pharmaceutics · 2021
- Interaction of Polymers with Enzalutamide Nanodroplets—Impact on Droplet Properties and Induction Times
Molecular Pharmaceutics · 2021
- Impact of Polymer Type on Thermal Degradation of Amorphous Solid Dispersions Containing Ritonavir
Molecular Pharmaceutics · 2021
- Optimization of Amorphization Kinetics during Hot Melt Extrusion by Particle Engineering: An Experimental and Computational Study
Crystal Growth & Design · 2021
- Crystallization Kinetics in Fasted-State Simulated and Aspirated Human Intestinal Fluids
Crystal Growth & Design · 2021
- Molecular Pharmaceutics×7
- Journal of Pharmaceutical Sciences×5
- Crystal Growth & Design×4
- European Journal of Pharmaceutical Sciences×3
- International Journal of Pharmaceutics×3
- Haichen Nie
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Tze Ning Hiew
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Laura I. Mosquera-Giraldo
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Alexandru Deac
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Hitesh S. Purohit
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile